MX2020012771A - Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida. - Google Patents
Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida.Info
- Publication number
- MX2020012771A MX2020012771A MX2020012771A MX2020012771A MX2020012771A MX 2020012771 A MX2020012771 A MX 2020012771A MX 2020012771 A MX2020012771 A MX 2020012771A MX 2020012771 A MX2020012771 A MX 2020012771A MX 2020012771 A MX2020012771 A MX 2020012771A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- phenylbenzo
- dihydro
- amine
- preparing substituted
- Prior art date
Links
- IKLWZGVCUZDMEL-UHFFFAOYSA-N 6-phenyl-5,6-dihydrobenzo[f]isoquinolin-2-amine Chemical class C1=NC(N)=CC(C2=CC=CC=C22)=C1CC2C1=CC=CC=C1 IKLWZGVCUZDMEL-UHFFFAOYSA-N 0.000 title 1
- 229940126062 Compound A Drugs 0.000 abstract 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562268758P | 2015-12-17 | 2015-12-17 | |
| PCT/US2016/067161 WO2017106639A1 (en) | 2015-12-17 | 2016-12-16 | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020012771A true MX2020012771A (es) | 2022-10-04 |
Family
ID=59057623
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020012771A MX2020012771A (es) | 2015-12-17 | 2016-12-16 | Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida. |
| MX2018007415A MX385672B (es) | 2015-12-17 | 2016-12-16 | Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-amina sustituida. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018007415A MX385672B (es) | 2015-12-17 | 2016-12-16 | Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-amina sustituida. |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US9834519B2 (https=) |
| EP (2) | EP3390368A4 (https=) |
| JP (2) | JP6940504B2 (https=) |
| KR (1) | KR20180085814A (https=) |
| CN (2) | CN114874149A (https=) |
| AU (2) | AU2016369520B2 (https=) |
| BR (1) | BR112018012325A2 (https=) |
| CA (1) | CA3006077A1 (https=) |
| EA (1) | EA201891431A1 (https=) |
| HK (1) | HK1255014A1 (https=) |
| IL (1) | IL259557A (https=) |
| MX (2) | MX2020012771A (https=) |
| NZ (1) | NZ742785A (https=) |
| SG (1) | SG11201804601TA (https=) |
| TW (1) | TWI748972B (https=) |
| WO (1) | WO2017106639A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3006077A1 (en) | 2015-12-17 | 2017-06-22 | Arqule, Inc. | Methods for preparing polymorphs of substituted 5,6-dihydrobenzo[h]quinazolin-2-amine |
| IL259556B2 (en) * | 2015-12-17 | 2023-09-01 | Arqule Inc | Solid forms of substituted 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine compounds |
| CN110669015A (zh) * | 2018-07-03 | 2020-01-10 | 上海喀露蓝科技有限公司 | 一种fgfr抑制剂的制备方法 |
| US10878412B2 (en) * | 2019-05-13 | 2020-12-29 | Truist Bank | In-line verification of transactions |
| WO2022053708A1 (en) | 2020-09-14 | 2022-03-17 | Basilea Pharmaceutica International AG | Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| EP0946523A1 (en) * | 1996-12-23 | 1999-10-06 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| EP1831207B1 (en) | 2004-12-17 | 2012-11-14 | Amgen Inc. | Aminopyrimidine compounds as plk inhibitors |
| JP2010514810A (ja) | 2006-12-29 | 2010-05-06 | ライジェル ファーマシューティカルズ， インコーポレイテッド | Ａｘｌインヒビターとして有用な置換トリアゾール |
| GB2449293A (en) * | 2007-05-17 | 2008-11-19 | Evotec | Compounds having Hsp90 inhibitory activity |
| TWI461410B (zh) * | 2008-12-30 | 2014-11-21 | Arqule Inc | 經取代之５，６－二氫－６－苯基苯並〔f〕異喹啉－２－胺化合物類 |
| US9012464B2 (en) | 2010-11-25 | 2015-04-21 | Ratiopharm Gmbh | Salts and polymorphic forms of Afatinib |
| WO2012177852A1 (en) * | 2011-06-24 | 2012-12-27 | Arqule, Inc | Substituted imidazopyridinyl compounds |
| CN106459993A (zh) * | 2014-03-31 | 2017-02-22 | 德彪药业国际股份公司 | Fgfr融合体 |
| CA3006077A1 (en) * | 2015-12-17 | 2017-06-22 | Arqule, Inc. | Methods for preparing polymorphs of substituted 5,6-dihydrobenzo[h]quinazolin-2-amine |
| IL259556B2 (en) | 2015-12-17 | 2023-09-01 | Arqule Inc | Solid forms of substituted 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine compounds |
-
2016
- 2016-12-16 CA CA3006077A patent/CA3006077A1/en active Pending
- 2016-12-16 NZ NZ742785A patent/NZ742785A/en not_active IP Right Cessation
- 2016-12-16 AU AU2016369520A patent/AU2016369520B2/en not_active Ceased
- 2016-12-16 HK HK18114135.7A patent/HK1255014A1/zh unknown
- 2016-12-16 US US15/381,418 patent/US9834519B2/en active Active
- 2016-12-16 CN CN202210565751.2A patent/CN114874149A/zh active Pending
- 2016-12-16 BR BR112018012325A patent/BR112018012325A2/pt not_active Application Discontinuation
- 2016-12-16 MX MX2020012771A patent/MX2020012771A/es unknown
- 2016-12-16 EA EA201891431A patent/EA201891431A1/ru unknown
- 2016-12-16 TW TW105141874A patent/TWI748972B/zh not_active IP Right Cessation
- 2016-12-16 EP EP16876767.1A patent/EP3390368A4/en not_active Withdrawn
- 2016-12-16 WO PCT/US2016/067161 patent/WO2017106639A1/en not_active Ceased
- 2016-12-16 SG SG11201804601TA patent/SG11201804601TA/en unknown
- 2016-12-16 MX MX2018007415A patent/MX385672B/es unknown
- 2016-12-16 EP EP21216064.2A patent/EP4015508A1/en active Pending
- 2016-12-16 JP JP2018531343A patent/JP6940504B2/ja not_active Expired - Fee Related
- 2016-12-16 CN CN201680081965.5A patent/CN108602779A/zh active Pending
- 2016-12-16 KR KR1020187020433A patent/KR20180085814A/ko not_active Ceased
-
2017
- 2017-11-01 US US15/800,648 patent/US10093632B2/en active Active
-
2018
- 2018-05-23 IL IL259557A patent/IL259557A/en unknown
-
2019
- 2019-04-22 US US16/390,205 patent/US10766868B2/en not_active Expired - Fee Related
- 2019-10-03 US US16/592,003 patent/US11279679B2/en active Active
-
2021
- 2021-04-28 AU AU2021202610A patent/AU2021202610B2/en not_active Ceased
- 2021-09-02 JP JP2021142864A patent/JP2021191782A/ja not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022009299A (es) | Derivado de quinolina muy puro y metodo para su produccion. | |
| PH12017500833A1 (en) | Synthesis of copanlisib and its dihydrochloride salt | |
| MY195183A (en) | Heterocyclic Amides as Kinase Inhibitors | |
| MX365494B (es) | Procedimiento de compuesto antifungico. | |
| EP3275883A4 (en) | Method for producing novel nitrogen-containing compound or salt thereof, and production intermediate of same | |
| MY183123A (en) | Synthesis of copanlisib and its di hydrochloride salt | |
| EP3216782A4 (en) | Iron amino acid compounds, method for preparing iron amino acid compounds, compositions containing iron amino acid compounds, and uses thereof | |
| MX369357B (es) | Procedimiento de compuesto antifungico. | |
| MX2020012771A (es) | Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida. | |
| WO2015068175A3 (en) | An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof | |
| MX2019001228A (es) | Metodo de produccion del compuesto de pirazol-amida. | |
| AU2016299728A8 (en) | Substituierted Furano-/Thienocycloalkylamino-2-Pyrimidine derivatives and use thereof for controlling undesired plant growth | |
| ZA201803105B (en) | Industrial process for the preparation of (5s,10s)-10-benzyl-16-methyl-11,14,18-trioxo-15,17,19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium (e)-3-carboxyacrylate salt | |
| EP3353149A4 (en) | PROCESS FOR THE PREPARATION OF INDOLIN COMPOUNDS AND A NOVEL INDOLIN SALT | |
| EP3118207A4 (en) | Inclusion compound of 3',5'-cyclicdiadenylic acid, and method for producing same | |
| IL258451B (en) | Salt type and crystal type of h4-pyrazolo[5,1-alpha]benzaimidazole compound and its preparation method and intermediate | |
| WO2017046816A3 (en) | Process for the preparation of derivatives of benzodioxole | |
| PH12019550212B1 (en) | Process for the preparation of pirlindole enantiomers and its salts | |
| MY174415A (en) | Salt form, crystal form and intermediate of 1,2,5-thiadiazolidine-1,1-dioxide and preparation method thereof | |
| WO2014136062A3 (en) | Process for the preparation of deferasirox | |
| AU2017904453A0 (en) | Process for preparing 2-substituted 3',4'-polyhydroxystilbene compounds | |
| IN2014CH01257A (https=) | ||
| HK1199024A1 (zh) | 可作為mogat-2抑制物使用之新型嗎啉基衍生物 |